We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Final Phase IIa Study Results Evaluating the CXCR4 Antagonist BL-8040 in Combination with Cytarabine (Ara-C) for the Treatment of Relapsed/Refractory AML Patients.
- Authors
Borthakur, Gautam; Tallman, Martin; Ofran, Yishai; Foran, James; Uy, Geoffrey; DiPersio, John; Nagler, Arnon; Rowe, Jacob; Showel, Margaret; Altman, Jessica; Peled, Amnon; Abraham, Michal; Pereg, Yaron; Vainstein, Abi; Oberkovitz, Galia; Lustig, Tzipi; Aharon, Arnon; Bueso-Ramos, Carlos; Cortes, Jorge; Andreeff, Michael
- Publication
Clinical Lymphoma, Myeloma & Leukemia, 2016, Vol 16, pS28
- ISSN
2152-2650
- Publication type
Article
- DOI
10.1016/j.clml.2016.07.040